Ho Yeong Lim

Researcher Next ID · RN-005756

Researcher · Medicine

Seoul, South Korea

Not currently recruitingFunding unknown

Research interests

Medicine

Hepatocellular Carcinoma Treatment and Prognosis

Colorectal Cancer Treatments and Studies

Gastric Cancer Management and Outcomes

Cholangiocarcinoma and Gallbladder Cancer Studies

Cancer Immunotherapy and Biomarkers

Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
Journal of Hepatology · 2021 · https://doi.org/10.1016/j.jhep.2021.11.030
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1915745
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.19.01307
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Nature Medicine · 2018 · https://doi.org/10.1038/s41591-018-0101-z
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
The Lancet · 2011 · https://doi.org/10.1016/s0140-6736(11)61613-9

No projects listed.